Cardiovascular system state changes in non-Hodgkin’s lymphoma patients during chemotherapy
Chemotherapy is one of reliable and proven methods of malignant tumor and blood diseases treatment but however the drug side effects (particularly cardiotoxicity) occur. More often cardiovascular complications connect with anthracyclines and related drugs (doxorubicin, daunorubicyn, epirubicyn, idar...
Saved in:
Main Authors: | A.-S. O. Bady, S. S. Fedorova, D. A. Yakhontov, T. I. Pospelova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2020-05-01
|
Series: | Сибирский научный медицинский журнал |
Subjects: | |
Online Access: | https://sibmed.elpub.ru/jour/article/view/374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01) -
The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01) -
The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01) -
Paraneoplastic Arthritis in a Patient with Non-Hodgkin’s Lymphoma
by: Guntur Darmawan, et al.
Published: (2017-11-01) -
Paraneoplastic Arthritis in a Patient with Non-Hodgkin’s Lymphoma
by: Guntur Darmawan, et al.
Published: (2017-11-01)